Short report: Common genotypic polymorphisms in glutathione S-transferases in mild and severe falciparum malaria in Tanzanian children

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 2, 2009, Pages 363-365

  Kavishe, Reginald A ^a   Bousema, Teun ^a   Shekalaghe, Seif A ^b   Sauerwein, Robert W ^a   Mosha, Frank W ^b   Van Der Ven, Andre J A M ^a   Russel, Frans G M ^a   Koenderink, Jan B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; REACTIVE OXYGEN METABOLITE;

ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HOST CELL; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRESCHOOL CHILD; SCHOOL CHILD; TANZANIA; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; PHYSIOLOGY;

PLASMODIUM FALCIPARUM;

CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALARIA, FALCIPARUM; MALE; POLYMORPHISM, GENETIC; TANZANIA;

EID: 68549136595     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.81.363     Document Type: Article

References (30)

1. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK, 2000. The structure of malaria pigment beta-haematin. Nature 404: 307-310.
2. Slater AF, 1993. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol Ther 57: 203-235.
3. Pandey AV, Bisht H, Babbarwal VK, Srivastava J, Pandey KC, Chauhan VS, 2001. Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem J 355: 333-338. (Pubitemid 32397791)
4. Maitland K, Marsh K, 2004. Pathophysiology of severe malaria in children. Acta Trop 90: 131-140.
5. Schwarzer E, Turrini F, Giribaldi G, Cappadoro M, Arese P, 1993. Phagocytosis of P falciparum malarial pigment hemozoin by human monocytes inactivates monocyte protein kinase C. Biochim Biophys Acta 1181: 51-54. (Pubitemid 23087521)
6. Schwarzer E, Arese P, 1996. Phagocytosis of malarial pigment hemozoin inhibits NADPH-oxidase activity in human monocyte-derived macrophages. Biochim Biophys Acta 1316: 169-175. (Pubitemid 26273701)
7. Taramelli D, Basilico N, Pagani E, Grande R, Monti D, Ghione M, Olliaro P, 1995. The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages. Exp Parasitol 81: 501-511. (Pubitemid 26027456)
8. Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H, 2004. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34: 163-189. (Pubitemid 38229822)
9. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J, 1997. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272: 10004-10012. (Pubitemid 27171673)
10. Strange RC, Jones PW, Fryer AA, 2000. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 112-113: 357-363. (Pubitemid 30138144)
11. Strange RC, Lear JT, Fryer AA, 1998. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact 111-112: 351-364. (Pubitemid 28271955)
12. Kavishe RA, Koenderink JB, McCall MB, Peters WH, Mulder B, Hermsen CC, Sauerwine RW, Russel FG, Van der Ven AJ, 2006. Short report: severe Plasmodium falciparum malaria in Cameroon: associated with the glutathione S-transferase M1 null genotype. Am J Trop Med Hyg 75: 827-829. (Pubitemid 351627525)
13. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwine R, Bousema T, 2007. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS Clin Trials 2: e1023.
14. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Peshu N, et al., 1995. Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
15. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A, 1989. Clinical features and prognostic indicators in pediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441-459. (Pubitemid 19161768)
16. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al., 1994. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300: 271-276. (Pubitemid 24151046)
17. Bröckmoller J, Kerb R, Drakoulis N, Nitz M, Roors I, 1993. Genotype and phenotype of glutathione S-transferase class isoenzymes and psi in lung cancer patients and controls. Lung Cancer 10: 273. (Pubitemid 23087898)
18. Watson MA, Stewart RK, Smith GBJ, Massey TE, Bell DA, 1998. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19: 275-280.
19. Mcglynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou TL, et al., 1995. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B-1. Proc Natl Acad Sci USA 92: 2384-2387.
20. Mukanganyama S, Masimirembwa CM, Naik YS, Hasler JA, 1997. Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A. Clin Chim Acta 265: 145-155. (Pubitemid 27438274)
21. Rossini A, Rapozo DC, Amorim LM, Macedo JM, Medina R, Neto JF, Gallo CV, Pinto LF, 2002. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 1: 233-240. (Pubitemid 38972404)
22. Tiemersma EW, Omer RE, Bunschoten A, van't Veer P, Kok FJ, Idris MO, Kadaru AM, Fedail SS, Kampman E, 2001. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 10: 785-791.
23. Zhao L, Alldersea J, Fryer A, Tighe A, Ollier B, Thomson W, Jones P, Strange R, 1994. Polymorphism at the glutathione S-transferase GSTM1 locus: a study of the frequencies of the GSTM1-A, B, A/B and null phenotypes in Nigerians. Clin Chim Acta 225: 85-88. (Pubitemid 24118488)
24. Schneider J, Bernges U, Philipp M, Woitowitz HJ, 2004. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 208: 65-74. (Pubitemid 38501785)
25. Hu X, Xia H, Srivastava SK, Herzog C, Awasthi YC, Ji XH, Zimniak P, Singh SV, 1997. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 238: 397-402. (Pubitemid 27464396)
26. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B, Jernström B, 1998. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19: 433-436. (Pubitemid 28375445)
27. Wang LH, Groves MJ, Hepburn MD, Bowen DT, 2000. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages. Haematologica 85: 573-579.
28. Famin O, Krugliak M, Ginsburg H, 1999. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Biochem Pharmacol 58: 59-68. (Pubitemid 29246074)
29. Ginsburg H, Famin O, Zhang JM, Krugliak M, 1998. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 56: 1305-1313. (Pubitemid 28511267)
30. Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H, 2003. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels. Biochem Pharmacol 66: 809-817. (Pubitemid 37011420)